Infectologia

M-A | Eficácia comparativa e segurança de intervenções farmacológicas para prevenir a transmissão mãe-filho do vírus da hepatite B.

21 Mar, 2022 | 15:49h

Comparative efficacy and safety of pharmacological interventions to prevent Mother-to-Child transmission of hepatitis B virus: A systematic review and network meta-analysis – American Journal of Obstetrics & Gynecology

---

Decisão do consenso de especialistas da ACC de 2022 sobre sequelas cardiovasculares de COVID-19 em adultos: miocardite e outros envolvimentos miocárdicos, sequelas pós-agudas da infecção pelo SARS-CoV-2 e volta aos esportes.

17 Mar, 2022 | 13:25h

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Comentários:

ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology

ACC Releases Guidance on CV Issues With COVID-19 – TCTMD

Pontos principais: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19

Conteúdos relacionados:

Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.

The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.

COVID-19 infections increase risk of heart conditions up to a year later, study finds.

 

Comentário no Twitter (fio – clique para saber mais)

Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem

— American College of Cardiology (@ACCinTouch) March 16, 2022

 

---

Evidências Cochrane | Tratamento para COVID-19 moderada a grave.

17 Mar, 2022 | 13:22h

Treatments for moderate to severe COVID-19: Cochrane evidence – Evidently Cochrane

---

Evidências Cochrane | Tratamento para COVID-19 leve.

17 Mar, 2022 | 13:20h

Treatments for mild COVID-19: Cochrane evidence – Cochrane Library

---

Entre profissionais da área da saúde, a efetividade da 4ª dose de vacina contra infecção pela variante Ômicron do SARS-CoV-2 foi de 30% para a Pfizer–BioNTech e 11% para a Moderna.

17 Mar, 2022 | 13:19h

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron – New England Journal of Medicine

Conteúdo relacionado: [Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.

---

Efetividade das vacinas Sputnik V, AstraZeneca e Sinopharm para o risco de infecção e morte por COVID-19 em idosos com mais de 60 anos na Argentina.

17 Mar, 2022 | 13:17h

Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study – The Lancet

Comentário: Evaluating COVID-19 vaccines in the real world – The Lancet

---

Tendências de tumores associados ao HPV, características demográficas e vacinação nos EUA, 2001-2017.

17 Mar, 2022 | 12:46h

Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 – JAMA Network Open

Entrevista com o autor: Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations

Conteúdos relacionados:

[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

---

Antibioticoterapias para prevenir exacerbações agudas recorrentes da doença pulmonar obstrutiva crônica (DPOC): além das diretrizes.

17 Mar, 2022 | 12:43h

Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines – Respiratory Research

---

Revisão | Papel dos exames de imagem nas raras complicações multiórgãos da vacina contra COVID-19.

16 Mar, 2022 | 17:49h

Role of imaging in rare COVID-19 vaccine multiorgan complications – Insights into Imaging

---

Avaliação quantitativa via tomografia computadorizada de tórax para doença de vias aéreas pequenas nos sintomas pós-agudos de infecção por SARS-CoV-2.

16 Mar, 2022 | 17:44h

Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection – Radiology

Comunicado de imprensa: ‘Long COVID’ linked to lasting airways disease – Radiological Society of North America

---